Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $30.8B
1-Year Est. Return 20.65%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+20.65%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$30.8B
AUM Growth
+$1.17B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,421
New
Increased
Reduced
Closed

Top Buys

1 +$698M
2 +$243M
3 +$232M
4
META icon
Meta Platforms (Facebook)
META
+$184M
5
AMZN icon
Amazon
AMZN
+$153M

Top Sells

1 +$542M
2 +$397M
3 +$132M
4
VICI icon
VICI Properties
VICI
+$112M
5
WELL icon
Welltower
WELL
+$80.2M

Sector Composition

1 Technology 31.24%
2 Real Estate 26.2%
3 Communication Services 11.89%
4 Consumer Discretionary 7.38%
5 Financials 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWZ icon
1126
iShares MSCI Brazil ETF
EWZ
$9.06B
$18K ﹤0.01%
580
-400
USHY icon
1127
iShares Broad USD High Yield Corporate Bond ETF
USHY
$26.3B
$18K ﹤0.01%
475
+161
KYMR icon
1128
Kymera Therapeutics
KYMR
$6.68B
$17K ﹤0.01%
215
PTCT icon
1129
PTC Therapeutics
PTCT
$5.24B
$17K ﹤0.01%
230
-20
PTGX icon
1130
Protagonist Therapeutics
PTGX
$5.83B
$17K ﹤0.01%
190
VGIT icon
1131
Vanguard Intermediate-Term Treasury ETF
VGIT
$39.1B
$16K ﹤0.01%
275
-126
CGC
1132
Canopy Growth
CGC
$393M
$15K ﹤0.01%
+13,900
COGT icon
1133
Cogent Biosciences
COGT
$6.08B
$15K ﹤0.01%
416
ACAD icon
1134
Acadia Pharmaceuticals
ACAD
$3.79B
$14K ﹤0.01%
530
APGE icon
1135
Apogee Therapeutics
APGE
$4.85B
$13K ﹤0.01%
166
CRNX icon
1136
Crinetics Pharmaceuticals
CRNX
$3.99B
$13K ﹤0.01%
282
-22
FOLD icon
1137
Amicus Therapeutics
FOLD
$4.5B
$13K ﹤0.01%
916
-70
GPCR icon
1138
Structure Therapeutics
GPCR
$4.22B
$13K ﹤0.01%
186
-40
IMVT icon
1139
Immunovant
IMVT
$5.44B
$13K ﹤0.01%
501
-80
SRRK icon
1140
Scholar Rock
SRRK
$4.71B
$13K ﹤0.01%
296
ADMA icon
1141
ADMA Biologics
ADMA
$3.74B
$12K ﹤0.01%
670
-80
AMRX icon
1142
Amneal Pharmaceuticals
AMRX
$4.17B
$12K ﹤0.01%
933
-90
MIRM icon
1143
Mirum Pharmaceuticals
MIRM
$5.26B
$12K ﹤0.01%
158
NAMS icon
1144
NewAmsterdam Pharma
NAMS
$3.47B
$12K ﹤0.01%
335
-40
ACLX icon
1145
Arcellx
ACLX
$6.61B
$11K ﹤0.01%
174
LGND icon
1146
Ligand Pharmaceuticals
LGND
$4.06B
$11K ﹤0.01%
58
-5
TARS icon
1147
Tarsus Pharmaceuticals
TARS
$3.19B
$11K ﹤0.01%
137
TERN icon
1148
Terns Pharmaceuticals
TERN
$4.57B
$11K ﹤0.01%
260
+109
ARQT icon
1149
Arcutis Biotherapeutics
ARQT
$2.94B
$10K ﹤0.01%
358
-1
CGON icon
1150
CG Oncology
CGON
$4.99B
$10K ﹤0.01%
239
+5